Holen Sie sich die Stockscreener-App
17.44
1.04%
0.18
Schlusskurs vom Vortag:
$17.26
Offen:
$17.26
24-Stunden-Volumen:
97,610
Relative Volume:
1.15
Marktkapitalisierung:
$224.14M
Einnahmen:
$16.96M
Nettoeinkommen (Verlust:
$-23.88M
KGV:
-8.3166
EPS:
-2.097
Netto-Cashflow:
$-20.66M
1W Leistung:
+5.31%
1M Leistung:
+3.75%
6M Leistung:
-3.91%
1J Leistung:
-1.52%
1-Tages-Spanne:
$17.13
$17.55
1-Wochen-Bereich:
$16.10
$17.55
52-Wochen-Spanne:
$14.90
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.44 | 224.14M | 16.96M | -23.88M | -20.66M | -2.097 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-02 | Eingeleitet | Alliance Global Partners | Buy |
| 2025-02-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-07-16 | Bestätigt | Maxim Group | Buy |
| 2022-12-22 | Eingeleitet | Maxim Group | Buy |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-09-23 | Eingeleitet | BTIG Research | Buy |
| 2016-11-28 | Eingeleitet | Aegis Capital | Buy |
| 2016-08-17 | Eingeleitet | Wells Fargo | Outperform |
| 2014-04-16 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
Liquidity Mapping Around (MDWD) Price Events - Stock Traders Daily
MediWound Ltd. (NASDAQ:MDWD) Given Consensus Rating of "Hold" by Analysts - MarketBeat
MediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market - TipRanks
Why (MDWD) Price Action Is Critical for Tactical Trading - Stock Traders Daily
MediWound (NASDAQ:MDWD) Share Price Crosses Above Fifty Day Moving AverageTime to Sell? - MarketBeat
Is MediWound (MDWD) stock forming a trend channel (Technical Weakness) 2026-04-20Income Investing - Cổng thông tin điện tử tỉnh Lào Cai
Shmuel Hess Net Worth (2026) - GuruFocus
Vickie Rae Driver Net Worth (2026) - GuruFocus
Kalfon Hana Luxenburg Net Worth (2026) - GuruFocus
Ety Klinger Net Worth (2026) - GuruFocus
Yaakov Aya Ben Net Worth (2026) - GuruFocus
MediWound highlights consensus supporting debridement strategy By Investing.com - Investing.com Australia
Breakouts Watch: Will MediWound Ltd benefit from sector rotation2026 Support & Resistance & Reliable Momentum Entry Alerts - baoquankhu1.vn
MediWound Highlights U.S. Expert Consensus Supporting EscharEx® Strategy for Chronic Wound Debridement - Quiver Quantitative
MediWound highlights consensus supporting debridement strategy - Investing.com
U.S. wound experts favor less invasive care, aligning with MediWound - Stock Titan
Understanding Momentum Shifts in (MDWD) - Stock Traders Daily
MediWound (NASDAQ:MDWD) Stock Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Published on: 2026-04-11 10:40:16 - baoquankhu1.vn
Wound Care Biologics Market Is Going to Boom | MediWound Ltd. • Acelity L.P. Inc. • Smith & Nephew plc - openPR.com
MediWound Ltd. (M8W.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences - Sahm
MDWD SEC FilingsMediwound 10-K, 10-Q, 8-K Forms - Stock Titan
Mediwound Ltd. Presents New Escharex Data At Wound Care Conferences - marketscreener.com
Why Vericel (VCEL) Is Up 11.8% After Landing Long-Term BARDA Deal For NexoBrid - simplywall.st
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million - Sahm
MediWound Ltd. (NASDAQ:MDWD) Given Average Rating of "Hold" by Brokerages - MarketBeat
MediWound (MDWD) Gains as Vericel Secures $197M Contract for Nex - GuruFocus
MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid - TipRanks
BARDA’s up-to-$197M NexoBrid contract highlighted by MediWound (MDWD) - Stock Titan
U.S. stockpile plans include NexoBrid under BARDA deal worth up to $197M - Stock Titan
MediWound and Vericel Secure Up to $197 Million BARDA Contract for NexoBrid® Procurement and Development - Quiver Quantitative
Aug Highlights: Is MediWound Ltd forming a bullish divergence2026 Sector Review & Technical Buy Zone Confirmations - baoquankhu1.vn
MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus - The Globe and Mail
Avoiding Lag: Real-Time Signals in (MDWD) Movement - Stock Traders Daily
MediWound (NASDAQ: MDWD) plans 2026 AGM, director slate and CEO bonus - Stock Titan
Fed Meeting: Should value investors consider MediWound LtdSell Signal & Daily Profit Focused Stock Screening - baoquankhu1.vn
MediWound (MDWD) director details options, RSU and share holdings - stocktitan.net
MediWound Ltd. (NASDAQ:MDWD) Q4 2025 earnings call transcript - msn.com
Gap Down: Can MediWound Ltd keep up with sector leaders2026 Sector Review & Smart Swing Trading Alerts - baoquankhu1.vn
Pullback Watch: Does MediWound Ltd meet Warren Buffetts criteriaEarnings Overview Report & Weekly Consistent Profit Watchlists - baoquankhu1.vn
MediWound (NASDAQ:MDWD) Stock Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Discipline and Rules-Based Execution in MDWD Response - Stock Traders Daily
Aug Drivers: Will MediWound Ltd outperform the market in YEARGap Down & Verified Short-Term Plans - baoquankhu1.vn
MediWound (MDWD) director Rubinstein reports options and share holdings - Stock Titan
[Form 3] MediWound Ltd. Initial Stateme... - Stock Titan
MediWound (MDWD) CMO details options and RSU awards in Form 3 filing - Stock Titan
MediWound Ltd. (MDWD) director discloses shares, RSUs and options stake - Stock Titan
MediWound (MDWD) VP reports stock options and RSU holdings in Form 3 - Stock Titan
MediWound (MDWD) EVP Meyer Yaron files Form 3 on equity holdings - Stock Titan
MediWound (MDWD) details director Stephen Wills’ initial share and option holdings - Stock Titan
Finanzdaten der Mediwound Ltd-Aktie (MDWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):